Insider Trading & Ownership of Jamie Dananberg

Location
Brisbane, CA
Summary
The estimated net worth of Jamie Dananberg is at least $786,005 dollars as of 04 Mar 2026. Jamie Dananberg is the CHIEF MEDICAL OFFICER of Annexon, Inc. and owns shares of Annexon, Inc. (ANNX) stock worth about $671K. Jamie Dananberg is the Chief Medical Officer of Unity Biotechnology, Inc. and owns shares of Unity Biotechnology, Inc. stock worth about $115K.
Signature
/s/ Jennifer Lew, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jamie Dananberg and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Jamie Dananberg has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $786,005.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Annexon, Inc. ($671,050).
  • Past-year value change for that position: -$58,582.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jamie Dananberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ANNX Annexon, Inc. Chief Medical Officer $671,050 -$58,582 -8% 02 Mar 2026
UBX Unity Biotechnology, Inc. Chief Medical Officer $114,955 31 Mar 2023

Insider Transactions Reported by Jamie Dananberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .